(US) F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm’s product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company is headquartered in Cambridge, the United Kingdom.
IG Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY.
Jiya Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in August 2020 and is headquartered in Palo Alto, CA.
(US) MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.
North Mountain Merger Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on July 14, 2020 and is headquartered New York, NY.
Oasis Petroleum, Inc. engages in the acquisition, development, and exploration of onshore, unconventional oil and natural gas resources. It operates through the following business segments: Exploration and Production, Midstream Services, and Well Services. The Exploration and Production segment refers to the sale of oil, and natural gas production. The Midstream Services segment performs salt water gathering, disposal services, fresh water services, natural gas gathering and processing as well as crude oil gathering and transportation, and other midstream services for the oil and natural gas wells. The Well Services segment relates to the completion services for the oil and natural gas wells as well as the products sales and equipment rentals. The company was founded by Thomas B. Nusz and Taylor L. Reid on March 8, 2007 and is headquartered in Houston, TX.
Recharge Acquisition Corp. operates as a blank check company. It is formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 7, 2020 and is headquartered in Sarasota, FL.
(United Kingdom) Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. Axovant operates through seven wholly owned subsidiaries and also has business operations in Basel, Switzerland and New York, NY. The company was founded on October 31, 2014 and is headquartered in New York, NY.
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world's biggest drivers of disease - inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company's primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.
Vinco Ventures, Inc. offers innovation sourcing, product design, sales, manufacturing, and fulfillment services. The company has a number of internally developed brands which act as a Launchpad for new items that have matriculated through the innovation portal. Its brands include Cloud B, Pirasta, Uber Mom, Best Party Concepts, Lily and Grey, Sol and Salud, Trillion Trees, Eco Quest, Smarter Specs, Barkley Lane, and Ngenious Fun. Additionally, the company offers a partnership model for entrepreneurs and businesses that are seeking to elevate their existing brands. In addition to developing products for its EN brands, the company develops and manufactures products for other brands in the entertainment and theme park industry. The company was founded on July 18, 2017 and headquartered in Bethlehem, PA.
Elys Game Technology Corp. is a vertically integrated commercial-stage company engaged in various aspects of the leisure gaming industry. It offers gaming services, including a variety of lottery, casino gaming and sports betting products through two distribution channels: an online channel and a land-based retail channel. The company operates its business through following segments: Betting establishments and Betting platform software and services. The Betting establishments segment offers leisure betting products to retail customers directly through online distribution on websites or a betting shop establishment or through third party agents that operate white-label websites and land-based retail venue. The Betting platform software and services segment provides platform and virtual sports products to betting operators. Newgioco Group was founded on August 26, 1998 and is headquartered in Toronto, Canada.
Eos Energy Enterprises, Inc. develops energy storage systems. It is designed to overcome the limitations of conventional lithium-ion technology. The company was founded in 2008 and is headquartered in Edison, NJ.
GCM Grosvenor, Inc. provides asset management and investment advisory services. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, and absolute return strategies. The firm specializes in developing customized portfolios for clients who want an active role in the development of their alternatives programs. It also offers multi-client portfolios for investors who desire a turn-key solution for accessing alternative investments. The firm’s offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments. The company was founded in 1971 and is headquartered in Chicago, IL.
InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.
Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. The firm uses biomarker technology to identify enzyme targets associated with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two major categories of compounds at various stages of pre-clinical and clinical development that the Company believes have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in East Setauket, NY.
(US) Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.
(IL) NeoGames SA provides online lottery software services. It operates as a global technology provider which is engaged in the development and operation of online lotteries and games, allowing lottery operators to distribute lottery products via online sales channels while using its technology. The firm's services include players support, CRM and analysis, payments and solutions, marketing, compliance and security. The company was founded on April 10, 2014 and is headquartered in Luxembourg.
Nisun International Enterprise Development Group Co., Ltd. engages in the development, manufacture, and provision of customized installation of valves and pipe fitting. Its products are used for pharmaceutical, biological, food and beverage, and other clean industries. It also offers steel fittings, sanitary pump, and filter. The company was founded on May 29, 2012 and is headquartered in Wenzhou, China.
(US) Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.